annual cash & cash equivalents:
$1.12B+$102.00M(+10.01%)Summary
- As of today (May 29, 2025), XYL annual cash & cash equivalents is $1.12 billion, with the most recent change of +$102.00 million (+10.01%) on December 31, 2024.
- During the last 3 years, XYL annual cash & cash equivalents has fallen by -$228.00 million (-16.90%).
- XYL annual cash & cash equivalents is now -40.21% below its all-time high of $1.88 billion, reached on December 31, 2020.
Performance
XYL Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.06B-$62.00M(-5.53%)Summary
- As of today (May 29, 2025), XYL quarterly cash & cash equivalents is $1.06 billion, with the most recent change of -$62.00 million (-5.53%) on March 31, 2025.
- Over the past year, XYL quarterly cash & cash equivalents has increased by +$112.00 million (+11.83%).
- XYL quarterly cash & cash equivalents is now -43.52% below its all-time high of $1.88 billion, reached on December 31, 2020.
Performance
XYL quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
XYL Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.0% | +11.8% |
| 3 y3 years | -16.9% | -5.2% |
| 5 y5 years | +54.8% | +43.3% |
XYL Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | +18.8% | -10.7% | +50.2% |
| 5 y | 5-year | -40.2% | +54.8% | -43.5% | +50.2% |
| alltime | all time | -40.2% | +1284.0% | -43.5% | +708.4% |
XYL Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.06B(-5.5%) |
| Dec 2024 | $1.12B(+10.0%) | $1.12B(+13.3%) |
| Sep 2024 | - | $989.00M(+21.3%) |
| Jun 2024 | - | $815.00M(-13.9%) |
| Mar 2024 | - | $947.00M(-7.1%) |
| Dec 2023 | $1.02B(+7.9%) | $1.02B(+44.5%) |
| Sep 2023 | - | $705.00M(-0.4%) |
| Jun 2023 | - | $708.00M(-15.4%) |
| Mar 2023 | - | $837.00M(-11.3%) |
| Dec 2022 | $944.00M(-30.0%) | $944.00M(-20.4%) |
| Sep 2022 | - | $1.19B(+6.6%) |
| Jun 2022 | - | $1.11B(-0.4%) |
| Mar 2022 | - | $1.12B(-17.2%) |
| Dec 2021 | $1.35B(-28.1%) | $1.35B(+7.5%) |
| Sep 2021 | - | $1.25B(-31.8%) |
| Jun 2021 | - | $1.84B(+9.0%) |
| Mar 2021 | - | $1.69B(-10.0%) |
| Dec 2020 | $1.88B(+159.0%) | $1.88B(+33.7%) |
| Sep 2020 | - | $1.40B(-11.1%) |
| Jun 2020 | - | $1.58B(+113.4%) |
| Mar 2020 | - | $739.00M(+2.1%) |
| Dec 2019 | $724.00M(+144.6%) | $724.00M(+59.8%) |
| Sep 2019 | - | $453.00M(+18.3%) |
| Jun 2019 | - | $383.00M(+39.3%) |
| Mar 2019 | - | $275.00M(-7.1%) |
| Dec 2018 | $296.00M(-28.5%) | $296.00M(-26.7%) |
| Sep 2018 | - | $404.00M(+25.9%) |
| Jun 2018 | - | $321.00M(+8.1%) |
| Mar 2018 | - | $297.00M(-28.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $414.00M(+34.4%) | $414.00M(+46.3%) |
| Sep 2017 | - | $283.00M(-1.7%) |
| Jun 2017 | - | $288.00M(+0.3%) |
| Mar 2017 | - | $287.00M(-6.8%) |
| Dec 2016 | $308.00M(-54.7%) | $308.00M(-53.3%) |
| Sep 2016 | - | $659.00M(+12.5%) |
| Jun 2016 | - | $586.00M(-50.9%) |
| Mar 2016 | - | $1.19B(+75.4%) |
| Dec 2015 | $680.00M(+2.6%) | $680.00M(+11.3%) |
| Sep 2015 | - | $611.00M(+1.8%) |
| Jun 2015 | - | $600.00M(+8.3%) |
| Mar 2015 | - | $554.00M(-16.4%) |
| Dec 2014 | $663.00M(+24.4%) | $663.00M(+25.3%) |
| Sep 2014 | - | $529.00M(+17.6%) |
| Jun 2014 | - | $450.00M(-3.4%) |
| Mar 2014 | - | $466.00M(-12.6%) |
| Dec 2013 | $533.00M(+5.8%) | $533.00M(+35.3%) |
| Sep 2013 | - | $394.00M(+9.4%) |
| Jun 2013 | - | $360.00M(-4.0%) |
| Mar 2013 | - | $375.00M(-25.6%) |
| Dec 2012 | $504.00M(+58.5%) | $504.00M(+18.9%) |
| Sep 2012 | - | $424.00M(+18.4%) |
| Jun 2012 | - | $358.00M(+3.2%) |
| Mar 2012 | - | $347.00M(+9.1%) |
| Dec 2011 | $318.00M(+142.7%) | $318.00M(+72.8%) |
| Sep 2011 | - | $184.00M(+19.5%) |
| Mar 2011 | - | $154.00M(+17.6%) |
| Dec 2010 | $131.00M(+61.7%) | $131.00M |
| Dec 2009 | $81.00M | - |
FAQ
- What is Xylem annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Xylem?
- What is Xylem annual cash & cash equivalents year-on-year change?
- What is Xylem quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Xylem?
- What is Xylem quarterly cash & cash equivalents year-on-year change?
What is Xylem annual cash & cash equivalents?
The current annual cash & cash equivalents of XYL is $1.12B
What is the all time high annual cash & cash equivalents for Xylem?
Xylem all-time high annual cash & cash equivalents is $1.88B
What is Xylem annual cash & cash equivalents year-on-year change?
Over the past year, XYL annual cash & cash equivalents has changed by +$102.00M (+10.01%)
What is Xylem quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of XYL is $1.06B
What is the all time high quarterly cash & cash equivalents for Xylem?
Xylem all-time high quarterly cash & cash equivalents is $1.88B
What is Xylem quarterly cash & cash equivalents year-on-year change?
Over the past year, XYL quarterly cash & cash equivalents has changed by +$112.00M (+11.83%)